NASDAQ: BIOL - BIOLASE, Inc.

Yield per half year: -84.5%
Dividend yield: 0.00%
Sector: Healthcare

Current price
0.1603 $
Average price
0.0444 $ -72.33%

Price based on EPS
0.6169 $ +284.85%
0/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 0.6169 $
Current price = 0.1603 $ (difference = +284.85%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -100.07 $
Current price = 0.1603 $ (difference = -62 526.24%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -127.29 $
Current price = 0.1603 $ (difference = -79 504.73%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription